Olanzapine ODT 5mg Tablets

Manufacturer APOTEX Active Ingredient Olanzapine Orally Disintegrating Tablets(oh LAN za peen) Pronunciation oh LAN za peen
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat bipolar disorder. It is used to treat schizophrenia.It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Atypical Antipsychotic
đŸ§Ŧ
Pharmacologic Class
Serotonin-Dopamine Antagonist (SDA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Olanzapine is a medication used to treat mental health conditions like schizophrenia and bipolar disorder. It helps to balance certain chemicals in the brain, which can improve mood, thoughts, and behavior. The ODT (Orally Disintegrating Tablet) form dissolves quickly in your mouth without water.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Be mindful of your fluid intake in hot weather or when engaging in physical activity to avoid dehydration. Drink plenty of fluids to replace lost fluids.
You can take this medication with or without food. If it causes stomach upset, take it with food to help minimize discomfort.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

Special Instructions for Taking Your Medication

When opening the foil packaging, do not push the tablet out. Instead, use dry hands to remove it from the foil.
Place the tablet on your tongue and allow it to dissolve. You do not need to drink water with it. Do not swallow the tablet whole, and avoid chewing, breaking, or crushing it.
If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light and moisture. Avoid storing it in a bathroom.
Use the oral-disintegrating tablet immediately after opening the pouch. Discard any unused portion of the pouch.
Keep all medications in a safe and secure location, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember.
If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants as they can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • Monitor your weight and diet, as olanzapine can cause weight gain and changes in blood sugar and cholesterol levels. Regular exercise and a healthy diet are important.
  • Avoid overheating and dehydration, as olanzapine can impair the body's ability to regulate temperature.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms or worsening of your condition.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial 5-10 mg once daily, target 10-15 mg once daily
Dose Range: 5 - 20 mg

Condition-Specific Dosing:

Schizophrenia: Initial 5-10 mg once daily, target 10-15 mg once daily. Max 20 mg/day.
Bipolar I Disorder (Manic or Mixed Episodes) Monotherapy: Initial 10-15 mg once daily. Max 20 mg/day.
Bipolar I Disorder (Manic or Mixed Episodes) Adjunctive to Lithium or Valproate: Initial 10 mg once daily. Max 20 mg/day.
Bipolar I Disorder (Maintenance): 10-20 mg once daily.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: For Schizophrenia (13-17 years): Initial 2.5-5 mg once daily, target 10 mg once daily. Max 20 mg/day. For Bipolar I Disorder (Manic or Mixed Episodes, 13-17 years): Initial 2.5-5 mg once daily, target 10 mg once daily. Max 20 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment generally required.
Moderate: No dosage adjustment generally required.
Severe: No dosage adjustment generally required, but caution is advised.
Dialysis: Not significantly removed by dialysis; no specific adjustment, but caution.

Hepatic Impairment:

Mild: No dosage adjustment generally required.
Moderate: Consider lower initial dose (e.g., 5 mg) and cautious titration.
Severe: Use with caution; consider lower initial dose and careful monitoring.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Olanzapine is an atypical antipsychotic that exhibits antagonism at multiple receptors, including dopamine D1, D2, D3, D4, D5, serotonin 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT6, adrenergic Îą1, histamine H1, and muscarinic M1, M2, M3, M4, M5 receptors. Its antipsychotic efficacy is believed to be mediated through a combination of dopamine and serotonin antagonism, particularly 5-HT2A and D2 receptor blockade.
📊

Pharmacokinetics

Absorption:

Bioavailability: 60%
Tmax: 5-8 hours
FoodEffect: Not significantly affected by food. ODT formulation is bioequivalent to the conventional tablet.

Distribution:

Vd: 1000 L
ProteinBinding: 93%
CnssPenetration: Yes

Elimination:

HalfLife: 21-54 hours (average 33 hours)
Clearance: Not available
ExcretionRoute: Urine (57%), Feces (30%)
Unchanged: 7% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Within hours to days for acute agitation/sedation; weeks for full antipsychotic effect.
PeakEffect: Not precisely defined for therapeutic effect; plasma peak at 5-8 hours.
DurationOfAction: 24 hours (once daily dosing)
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Olanzapine is not approved for the treatment of patients with dementia-related psychosis. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of olanzapine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Neurological problems, such as:
+ Trouble controlling body movements
+ Twitching
+ Change in balance
+ Trouble swallowing or speaking
Mental, mood, or behavior changes that are new or worsening, including:
+ Thoughts of hurting yourself or suicide
Severe dizziness or passing out
Abnormal heartbeat (fast or slow)
Not sweating during activities or in warm temperatures
Seizures
Drooling
Changes in eyesight
Memory problems or loss
Chest pain
Swelling
Burning, numbness, or tingling sensations that are not normal
Trouble passing urine
Hormonal changes, such as:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction
+ Menstrual changes
Swollen glands
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention immediately if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle problem, characterized by:
+ Trouble controlling body movements
+ Problems with your tongue, face, mouth, or jaw, such as:
- Tongue sticking out
- Puffing cheeks
- Mouth puckering
- Chewing

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:

Feeling dizzy, sleepy, tired, or weak
Restlessness
Shakiness
Headache
Constipation
Dry mouth
Upset stomach
Weight gain
Increased appetite
Back pain
Joint pain
Trouble sleeping

If you experience any of these side effects or any other unusual symptoms, contact your doctor for advice. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever, muscle stiffness, confusion, sweating, or fast/irregular heartbeat (signs of Neuroleptic Malignant Syndrome)
  • Uncontrolled movements of your face, tongue, or other body parts (signs of tardive dyskinesia)
  • Increased thirst, frequent urination, increased hunger, or unusual weakness (signs of high blood sugar/diabetes)
  • Dizziness or lightheadedness when standing up (orthostatic hypotension)
  • Severe allergic reaction (rash, hives, swelling of face/lips/tongue, difficulty breathing)
  • Thoughts about suicide or self-harm, or worsening depression/anxiety
  • Seizures
  • Yellowing of skin or eyes (jaundice)
  • Sore throat, fever, or other signs of infection (rare blood problems)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor identify potential interactions between this medication and other substances.
* Any existing health problems, as this medication may interact with certain conditions.

To ensure your safety, it is crucial to verify that this medication can be taken with all your current medications and health conditions. Never start, stop, or adjust the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position, and be cautious when climbing stairs.

Metabolic and Cardiovascular Risks
Drugs similar to this one have been associated with increased risks of high blood sugar, diabetes, high cholesterol, and weight gain, which may contribute to the development of heart and brain blood vessel disease. Therefore, it is crucial to:

Monitor your blood sugar levels as directed by your doctor
Undergo regular blood work and other laboratory tests as advised by your doctor

Interactions with Other Substances
Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or prescription/over-the-counter drugs that may cause drowsiness, consult with your doctor.

Potential Side Effects
This medication may cause dizziness, drowsiness, and impaired stability, which can increase the risk of falls, broken bones, and other health problems.

Severe and Potentially Life-Threatening Reaction
In rare cases, a severe and potentially deadly reaction may occur, characterized by symptoms such as fever, rash, swollen glands, and problems in organs like the liver, kidney, blood, heart, muscles and joints, or lungs. If you have any questions or concerns, discuss them with your doctor.

Special Considerations for Older Adults and Children
Older adults with dementia who take medications like this one may have a higher risk of stroke, which can be fatal. This medication is not approved for treating dementia-related mental health issues. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

When administering this medication to children, use caution, as the risk of certain side effects may be higher in this population.

Reproductive and Pregnancy Considerations
This medication may affect fertility, but this effect is reversible when the medication is discontinued. If you have questions, consult with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the benefits and risks of this medication to both you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Slurred speech
  • Agitation
  • Tachycardia (fast heart rate)
  • Extrapyramidal symptoms (e.g., tremor, rigidity)
  • Coma
  • Respiratory depression
  • Hypotension
  • Seizures
  • Cardiac arrhythmias

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining an open airway, oxygenation, and managing symptoms (e.g., IV fluids for hypotension, benzodiazepines for seizures).

Drug Interactions

🔴

Major Interactions

  • CNS depressants (e.g., alcohol, benzodiazepines, opioids): Increased sedation, respiratory depression.
  • Drugs that prolong QT interval (e.g., quinidine, sotalol, thioridazine): Additive QT prolongation risk.
  • Dopamine agonists (e.g., levodopa, bromocriptine): Olanzapine may antagonize their effects.
  • CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): Increased olanzapine plasma levels.
  • CYP1A2 inducers (e.g., carbamazepine, rifampin, omeprazole, smoking): Decreased olanzapine plasma levels.
🟡

Moderate Interactions

  • Anticholinergic agents: Potentiation of anticholinergic effects (e.g., constipation, dry mouth, blurred vision, urinary retention).
  • Antihypertensive agents: Additive hypotensive effects, particularly orthostatic hypotension.
  • Valproate: Increased risk of neutropenia when co-administered with olanzapine.
  • Lithium: No significant pharmacokinetic interaction, but monitor for adverse effects.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Weight/BMI

Rationale: Risk of weight gain and metabolic syndrome.

Timing: Before initiation

Fasting Plasma Glucose (FPG) or HbA1c

Rationale: Risk of hyperglycemia and diabetes.

Timing: Before initiation

Lipid Panel (Fasting)

Rationale: Risk of dyslipidemia.

Timing: Before initiation

Blood Pressure

Rationale: Risk of orthostatic hypotension.

Timing: Before initiation

Personal/Family History of Cardiovascular Disease, Diabetes, Dyslipidemia

Rationale: Identify risk factors for metabolic adverse effects.

Timing: Before initiation

Complete Blood Count (CBC)

Rationale: Rare risk of leukopenia/neutropenia.

Timing: Before initiation

Liver Function Tests (LFTs)

Rationale: Rare risk of hepatic enzyme elevations.

Timing: Before initiation

ECG

Rationale: Consider for patients with cardiac risk factors or history of arrhythmias due to potential for QT prolongation.

Timing: Before initiation (if indicated)

📊

Routine Monitoring

Weight/BMI

Frequency: Monthly for first few months, then quarterly

Target: Stable

Action Threshold: Significant weight gain (e.g., >5% baseline) warrants intervention.

Fasting Plasma Glucose (FPG) or HbA1c

Frequency: At 3 months, then annually

Target: FPG <100 mg/dL, HbA1c <5.7%

Action Threshold: FPG â‰Ĩ126 mg/dL or HbA1c â‰Ĩ6.5% (diabetes diagnosis); FPG 100-125 mg/dL or HbA1c 5.7-6.4% (prediabetes).

Lipid Panel (Fasting)

Frequency: At 3 months, then annually

Target: LDL <100 mg/dL, HDL >40 mg/dL (men), >50 mg/dL (women), Triglycerides <150 mg/dL

Action Threshold: Dyslipidemia requiring intervention.

Blood Pressure

Frequency: At each visit

Target: <120/80 mmHg

Action Threshold: Sustained hypertension or symptomatic orthostatic hypotension.

Abnormal Involuntary Movement Scale (AIMS)

Frequency: Annually (or more frequently if symptoms develop)

Target: No abnormal movements

Action Threshold: Emergence or worsening of tardive dyskinesia.

Extrapyramidal Symptoms (EPS) assessment

Frequency: At each visit

Target: No EPS

Action Threshold: Emergence of parkinsonism, akathisia, dystonia.

đŸ‘ī¸

Symptom Monitoring

  • Sedation/Drowsiness
  • Dizziness/Orthostatic Hypotension
  • Anticholinergic effects (dry mouth, constipation, blurred vision, urinary retention)
  • Weight gain
  • Symptoms of hyperglycemia (polyuria, polydipsia, polyphagia)
  • Symptoms of dyslipidemia
  • Extrapyramidal symptoms (tremor, rigidity, akathisia, dystonia)
  • Tardive dyskinesia (involuntary movements of face, tongue, limbs)
  • Neuroleptic Malignant Syndrome (fever, muscle rigidity, altered mental status, autonomic instability)
  • Suicidal ideation or worsening of depression (especially in children, adolescents, young adults)
  • Seizures
  • Rash or allergic reactions

Special Patient Groups

🤰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but no clear evidence of increased major malformation risk.
Second Trimester: Not available
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms (e.g., agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder) in neonates. Monitor neonates for these symptoms.
🤱

Lactation

Olanzapine is excreted into breast milk. The American Academy of Pediatrics considers it to be of unknown effect on the nursing infant but may be of concern. Monitor breastfed infants for sedation, irritability, poor feeding, and weight gain. Weigh the benefits of breastfeeding against the potential risks to the infant.

Infant Risk: L3 (Moderately Safe) - Detectable in milk, monitor infant for sedation, poor feeding, weight gain. Some sources suggest L4 (Possibly Hazardous) due to potential for long-term effects.
đŸ‘ļ

Pediatric Use

Safety and efficacy not established in children under 13 years of age. Use in adolescents (13-17 years) for schizophrenia and bipolar I disorder is established, but with a Black Box Warning regarding increased risk of suicidal thoughts and behaviors. Monitor closely for metabolic side effects (weight gain, dyslipidemia, hyperglycemia) which may be more pronounced in this population.

👴

Geriatric Use

Elderly patients with dementia-related psychosis treated with olanzapine are at an increased risk of death (Black Box Warning). Olanzapine is not approved for this indication. Elderly patients may be more susceptible to orthostatic hypotension, anticholinergic effects, and metabolic side effects. Use lower initial doses and titrate slowly, monitoring closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Olanzapine ODT (Orally Disintegrating Tablet) should be administered immediately upon removal from the blister pack. Do not chew or crush the tablet; allow it to dissolve on the tongue and then swallow with saliva.
  • Due to the risk of significant weight gain and metabolic abnormalities (hyperglycemia, dyslipidemia), thorough baseline and ongoing monitoring of weight, BMI, fasting glucose, and lipid profiles is crucial.
  • Patients should be educated on the importance of healthy lifestyle choices (diet, exercise) to mitigate metabolic risks.
  • Olanzapine can cause sedation; advise patients to take it at bedtime if possible, and to avoid activities requiring mental alertness until they know how the medication affects them.
  • The Black Box Warning for increased mortality in elderly patients with dementia-related psychosis is critical; olanzapine should not be used for this indication.
  • Monitor for extrapyramidal symptoms (EPS) and tardive dyskinesia, especially with long-term use. Consider using AIMS scale regularly.
🔄

Alternative Therapies

  • Other atypical antipsychotics (e.g., Aripiprazole, Quetiapine, Risperidone, Ziprasidone, Lurasidone, Cariprazine, Brexpiprazole)
  • First-generation antipsychotics (e.g., Haloperidol, Chlorpromazine) - generally less preferred due to higher EPS risk
  • Mood stabilizers (e.g., Lithium, Valproate, Lamotrigine) for bipolar disorder
  • Antidepressants (for depressive episodes in bipolar disorder, often with a mood stabilizer or antipsychotic)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy, Family-Focused Therapy)
💰

Cost & Coverage

Average Cost: Varies, typically $10-$50 per 30 tablets (generic 5mg ODT)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or higher (brand), varies by insurance plan
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information about your treatment. Please read this guide carefully and review it again whenever you receive a refill of your medication. If you have any questions or concerns about your medication, don't hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount consumed, and the time it occurred. This information will help healthcare professionals provide you with the most effective treatment.